首页> 美国卫生研究院文献>BMC Research Notes >Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

【2h】

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

机译：接受抗逆转录病毒治疗的HIV-HCV合并感染患者的肝脂肪变性与HCV相关因素有关但与抗逆转录病毒药物无关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundIn HIV and hepatitis C virus (HCV) coinfected patients, the role of antiretroviral therapy (ART) on hepatic steatosis (HS) remains controversial.

机译：背景在HIV和丙型肝炎病毒（HCV）合并感染的患者中，抗逆转录病毒疗法（ART）对肝脂肪变性（HS）的作用仍存在争议。

著录项

期刊名称 BMC Research Notes
作者
Valrie Martinez; Thi Dieu Ngan TA; Zahra Mokhtari; Marguerite Guiguet; Patrick Miailhes; Marc-Antoine Valantin; Frderic Charlotte; Philippe Bertheau; Jean-Michel Molina; Christine Katlama; Eric Caumes;
展开▼
作者单位

展开▼
年(卷),期 2012(5),-1
年度 2012
页码 180
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
HIV HCV steatosis antiretroviral drugs genotype 3;

机译：HIV;HCV;脂肪变性;抗逆转录病毒药物;基因型3;

相似文献

外文文献
中文文献
专利

1. Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals [J] . Valérie Martinez, Thi Dieu Ngan TA, Zahra Mokhtari, Genome Biology . 2013,第3期

机译：接受抗逆转录病毒治疗的HIV-HCV辛感染患者的肝脏脂肪变性与HCV相关因素相关但不是抗逆转录病毒
2. Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals [J] . Valrie Martinez, Thi Dieu Ngan TA, Zahra Mokhtari, BMC research notes . 2012,第1期

机译：接受抗逆转录病毒治疗的HIV-HCV合并感染患者的肝脂肪变性与HCV相关因素相关，但与抗逆转录病毒药物无关
3. Hepatic Steatosis and Fibrosis Diagnosed by Transient Elastography with Controlled Attenuation Parameter in Canadians Living with HIV Receiving Antiretroviral Therapy: Results of a Screening Program of 1033 Patients [J] . Sebastiani Giada, Ghali Peter, Wong Philip, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：肝脏脂肪变性和纤维化，瞬态弹性成像诊断，加拿大艾滋病毒接受抗逆转录病毒治疗的加拿大人控制衰减参数：1033名患者的筛查程序结果
4. The Effectiveness of an Antiretroviral Treatment (ARV) and a Highly Active Antiretroviral Therapy (HAART) on HIV/AIDS Epidemic Model [C] . Ummu Habibah, Ririt Andria Sari Basic Science International Conference . 2018

机译：抗逆转录病毒治疗（ARV）和高活性抗逆转录病毒治疗（HAART）对艾滋病毒/艾滋病流行病模型的有效性
5. Factors that influence risk behavior in HIV infected women receiving antiretroviral therapy in Kampala and Masaka, Uganda. [D] . MacLachlan, Ellen W. 2008

机译：影响乌干达坎帕拉和马萨卡接受抗逆转录病毒疗法的感染艾滋病毒的妇女的危险行为的因素。
6. Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals [O] . Valérie Martinez, Thi Dieu Ngan TA, Zahra Mokhtari, 2012

机译：HIV-HCV合并感染患者的肝脂肪变性抗逆转录病毒疗法与HCV相关因素有关但与抗逆转录病毒药
7. Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals [O] . 2013

机译：接受抗逆转录病毒治疗的HIV-HCV合并感染患者的肝脂肪变性与HCV相关因素有关，但与抗逆转录病毒药物无关

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅